September 08, 2016
1 min read
Save

Latest DOPPS data shows changes in intradialytic weight loss, Vitamin D prescriptions

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

As a percentage of post-dialysis body weight, intradialytic weight loss has steadily declined from 3.2% in August 2010 to 2.7% in June 2016, suggesting decreases in Interdialytic Weight Gain over time, according to the latest data from the Dialysis Outcomes and Practice Patterns Study (DOPPS) Practice Monitor. DOPPS researchers will discuss this trend, including potential causes and implications, during a web conference on Thursday, Sept. 15, 2016 at 3 p.m. EDT. The discussion will cover the latest trends in U.S. hemodialysis data from the DPM (available at www.DOPPS.org/DPM) through June 2016. Register here .

Other featured topics:

Anemia Management: The DOPPS Practice Monitor has noted a substantial trend in the types of ESA prescribed to US hemodialysis (HD) patients. Mircera (pegylated epoetin beta) use has quickly risen among large dialysis organization (LDO) facilities. As of June 2016, Mircera is estimated to be used by 43% of patients overall (from 0% as recently as March 2015). Researchers will review the current mix of ESA use, and discuss the observed hemoglobin levels for each type, as well as other trends relevant to anemia management. View graphics showing ESA use by type.

Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD) Management: The DPM has noted changes in Vitamin D prescriptions, used for PTH management, regarding type of vitamin D and administration route. In June 2016, IV vitamin D use (primarily doxercalciferol) was reported for approximately 50% of patients, down from 70% in 2014. Meanwhile, prescription of oral calcitriol was reported for more than 30% of patients, up from less than 5% in 2014. Researchers will review the current breakdown of CKD-MBD treatments and discuss the potential impact of these changes in U.S. hemodialysis patients.  View graphics showing vitamin D use by type.

About the DPM: The DPM is based on a sample of over 11,000 patients in more than 200 US hemodialysis facilities. The DPM provides regular updates of more than 1,500 figures and data tables on HD practices and patient characteristics since 2010. The DPM also provides patient-reported quality of life (QOL) data for download, including the Mental Composite Summary (MCS) and Physical Composite Summary (PCS) score distributions from the KDQOL-36© (Hays, 1994) for the DPM US national sample. Research papers describing DPM methods, key recent findings and analysis, and commentary have been published.